In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| 10-K | 8-K | 10-K | 8-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Licensing revenues | | 1.0 | | 7.9 | | | | |
Research and development | | 15.9 | | 15.6 | | | | |
Total revenues [+] | 2.0 | 17.0 | 9.1 | 23.4 | 6.9 | 0.0 | 2.8 | 5.3 |
Licensing | | 1.0 | | 7.9 | | | | |
Royalties | | 15.9 | | 15.6 | | | | |
Revenue growth [+] | -78.5% | -27.6% | 31.8% | | | -100.0% | -46.8% | -36.3% |
Licensing revenues | | -86.8% | | | | | | |
Research and development | | 2.4% | | | | | | |
Cost of goods sold | 0.0 | 30.9 | 0.0 | 29.9 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 2.0 | -14.0 | 9.1 | -6.5 | 6.9 | 0.0 | 2.8 | 5.3 |
Gross margin | 100.0% | -82.4% | 100.0% | -27.6% | 100.0% | | 100.0% | 100.0% |
Selling, general and administrative [+] | 43.5 | 8.7 | 20.2 | 4.6 | 11.9 | 7.1 | 15.7 | 11.7 |
General and administrative | | 8.7 | | 4.6 | 11.9 | 7.1 | 15.7 | 11.7 |
Research and development | | | | | 22.3 | 23.0 | 50.3 | 53.7 |
Other operating expenses | 43.8 | | 1.4 | | 28.3 | | | |
EBITDA [+] | -85.2 | | -12.4 | | -54.9 | -29.0 | -61.4 | -58.6 |
EBITDA growth | 585.1% | 104.4% | -77.3% | | 89.3% | -52.8% | 4.8% | 57.7% |
EBITDA margin | -4364.1% | -133.6% | -136.8% | -47.3% | -795.5% | | -2162.1% | -1096.6% |
Depreciation and amortization | 0.1 | | 0.1 | | 0.8 | 1.1 | 1.8 | 1.4 |
EBIT [+] | -85.3 | -22.7 | -12.5 | -11.1 | -55.6 | -30.0 | -63.2 | -60.0 |
EBIT growth | 580.4% | 104.4% | -77.5% | | 85.2% | -52.5% | 5.4% | 60.1% |
EBIT margin | -4369.2% | -133.6% | -137.9% | -47.3% | -806.7% | | -2224.7% | -1122.9% |
Non-recurring items [+] | | 18.9 | | | | | | |
In-process research & development | | 18.9 | | | | | | |
Interest expense, net [+] | | | | | 1.9 | 1.2 | -0.9 | -0.6 |
Interest expense | 3.7 | | 1.3 | | 1.9 | 1.2 | | |
Interest income | | | | | | | 0.9 | 0.6 |
Other income (expense), net [+] | 25.7 | -21.9 | 2.0 | -0.7 | 0.0 | 0.0 | 0.5 | -0.1 |
Gain (loss) on debt retirement | | 0.3 | | 1.7 | | -0.5 | | |
Change in fair value of warrants | | | | | 0.1 | 0.0 | | |
Other | | 0.1 | | 0.0 | | | 0.5 | -0.1 |
Pre-tax income | -63.4 | -63.4 | -11.8 | -11.8 | -57.5 | -31.2 | -61.8 | -59.4 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Minority interest | | 0.0 | | | | | | |
Net income | -63.4 | -63.4 | -11.8 | -11.8 | -50.8 | -31.2 | -61.8 | -59.4 |
Net margin | -3246.7% | -373.7% | -130.0% | -50.4% | -736.5% | | -2177.2% | -1112.8% |
|
Basic EPS [+] | ($12.87) | ($12.87) | ($2.71) | ($2.71) | ($21.57) | ($14.71) | ($1.61) | ($2.34) |
Growth | 374.7% | 374.7% | -87.4% | | 46.7% | 815.7% | -31.3% | 13.6% |
Diluted EPS [+] | ($12.87) | ($12.87) | ($2.71) | ($2.71) | ($21.57) | ($14.71) | ($1.61) | ($2.34) |
Growth | 374.7% | 374.7% | -87.4% | | 46.7% | 815.7% | -31.3% | 13.6% |
|
Shares outstanding (basic) [+] | 4.9 | 4.9 | 4.4 | 4.4 | 2.4 | 2.1 | 38.5 | 25.4 |
Growth | 13.0% | 13.0% | 85.1% | | 10.9% | -94.5% | 51.5% | 35.4% |
Shares outstanding (diluted) [+] | 4.9 | 4.9 | 4.4 | 4.4 | 2.4 | 2.1 | 38.5 | 25.4 |
Growth | 13.0% | 13.0% | 85.1% | | 10.9% | -94.5% | 51.5% | 35.4% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |